CompoAtlas

Three Legs Fevaco Capsule

Three Legs Fevaco Capsule : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Registration number
MAL21106157T
Type
Natural product
Published status
PRODUCT APPROVED
Licence holder
SYARIKAT WEN KEN DRUG SDN. BHD.
Manufacturer
SYARIKAT WEN KEN DRUG SDN. BHD.
Registration period starting
2026-10-28
Published validity end
2031-10-28

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
Polygonum cuspidatumPolygonum cuspidatum[75 mg,520 mg]Not identified
Forsythia suspensaForsythia suspensa[72 mg,520 mg]Not identified
Bupleurum chinenseBupleurum chinense[72 mg,520 mg]Not identified
Isatis indigoticaIsatis indigotica[60 mg,520 mg]Not identified
Patrinia villosaPatrinia villosa[45 mg,520 mg]Not identified
Glycyrrhiza uralensisGlycyrrhiza uralensis[36 mg,520 mg]Not identified
Verbena officinalisVerbena officinalis[21.2 mg,520 mg]Not identified
Phragmites communisPhragmites communis[19.3 mg,520 mg]Not identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Original register data

View published fields and their variants
Active ingredients
Polygonum cuspidatum[75 mg,520 mg],Forsythia suspensa[72 mg,520 mg],Bupleurum chinense[72 mg,520 mg],Isatis indigotica[60 mg,520 mg],Patrinia villosa[45 mg,520 mg],Glycyrrhiza uralensis[36 mg,520 mg],Verbena officinalis[21.2 mg,520 mg],Phragmites communis[19.3 mg,520 mg]
Valid until
2031-10-28
Registration date
2026-10-28
Published description
NATURAL PRODUCT
Licence holder
SYARIKAT WEN KEN DRUG SDN. BHD.
Producer
SYARIKAT WEN KEN DRUG SDN. BHD.
Published name
Three Legs Fevaco Capsule
Published reference
202104015168T
Registration number
MAL21106157T
Published status
PRODUCT APPROVED

Official source

View the official register, number MAL21106157T

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Glycyrrhiza uralensis
    Read the warning, when it applies and the studies cited

    DEGLYCYRRHIZINATED LICORICE Buccal

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 31 October 2025

    Deglycyrrhizinated Licorice Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 31 January 2025

    LICORICE

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (Gardner and McGuffin 2013).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Cough relief.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if cough worsens or persists (for) more than 1 week (EMA 2012).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Gastritis relief.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Contraindications

    Condition of application: All products.

    Do not use if you are pregnant (EMA 2012).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Do not use if you have hypokalemia, high blood pressure, or a kidney, liver or cardiovascular disorder (EMA 2012; Brinker 2010; ESCOP 2003; Bradley 1992).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Do not use if you are taking heart medications, corticosteroids, stimulant laxatives, or other health products that may contribute electrolyte imbalance (Brinker 2010; ESCOP 2003; Hoffmann 2003; Blumenthal et al. 2000).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 29 November 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line